Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: A phase II study

被引：0
|
作者：
Orditura, M.
Aurilio, G.
Galizia, G.
Carlomagno, C.
Lieto, E.
Vecchione, L.
Martinelli, E.
De Placido, S.
Catalano, G.
Ciardiello, F.
De Vita, F.
机构：
[1] Univ Naples, Cattedra Oncol Med, Naples, Italy
[2] Univ Naples, Cattedra Chirurg Gen & Epatobiliare, Naples, Italy
[3] Univ Naples Federico II, Dipartimento Endocrinol & Oncol Mol & Clin, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI52 / XI52
页数：1
相关论文
共 50 条
  • [21] Phase II trial of weekly docetaxel and capecitabine in advanced renal cell carcinoma.
    Vaishampayan, UN
    Heilbrun, LK
    Eliason, J
    Pontes, E
    Forman, J
    Cher, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 424S - 424S
  • [22] A pilot phase II study of capecitabine in advanced or recurrent gastric cancer
    Koizumi, W
    Saigenji, K
    Ujiie, S
    Terashima, M
    Sakata, Y
    Taguchi, T
    ONCOLOGY, 2003, 64 (03) : 232 - 236
  • [23] Capecitabine and docetaxel for advanced gastric cancer.
    Thuss-Patience, P. C.
    Kretzschmar, A.
    Dogan, Y.
    Blau, I.
    Pink, D.
    Lebedinzew, B.
    Micheel, S.
    Dörken, B.
    Reichardt, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 195S - 195S
  • [24] A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer
    Jen-Shi Chen
    Yen-Yang Chen
    Jen-Sheng Huang
    Kun-Yun Yeh
    Ping-Tsung Chen
    Wen-Chi Shen
    Hung-Chih Hsu
    Yung-Chung Lin
    Hung-Ming Wang
    Gastric Cancer, 2012, 15 : 49 - 55
  • [25] A phase II study of weekly low-dose docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer
    Chen, J. S.
    Shen, W. C.
    Chen, Y. Y.
    Huang, J. S.
    Yeh, K. Y.
    Chen, P. T.
    Hsu, H. C.
    Lin, Y. C.
    Wang, H. M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 375 - 376
  • [26] A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer
    Chen, Jen-Shi
    Chen, Yen-Yang
    Huang, Jen-Sheng
    Yeh, Kun-Yun
    Chen, Ping-Tsung
    Shen, Wen-Chi
    Hsu, Hung-Chih
    Lin, Yung-Chung
    Wang, Hung-Ming
    GASTRIC CANCER, 2012, 15 (01) : 49 - 55
  • [27] Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
    Sym, Sun Jin
    Ryu, Min-Hee
    Kang, Hye Jin
    Lee, Sung Sook
    Chang, Heung-Moon
    Lee, Jae Lyun
    Kim, Tae Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 373 - 380
  • [28] Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer
    Chun, JH
    Kim, HK
    Lee, JS
    Choi, JY
    Hwangbo, B
    Lee, HG
    Park, SR
    Choi, IJ
    Kim, CG
    Ryu, KW
    Kim, YW
    Lee, JS
    Bae, JM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (02): : 188 - 194
  • [29] Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
    Sun Jin Sym
    Min-Hee Ryu
    Hye Jin Kang
    Sung Sook Lee
    Heung-Moon Chang
    Jae Lyun Lee
    Tae Won Kim
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 373 - 380
  • [30] Phase I study of treatment with Gemcitabine and Docetaxel weekly in advanced pancreatic cancer
    Ridwelski, K
    Lueck, A
    Fahlke, J
    Lippert, H
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1025 - 1028
12345